Profound Medical
PROF
46 hedge funds and large institutions have $110M invested in Profound Medical in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
58% more call options, than puts
Call options by funds: $4.39M | Put options by funds: $2.78M
4.29% more ownership
Funds ownership: 42.78% → 47.07% (+4.3%)
0% more funds holding
Funds holding: 46 → 46 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
14% less capital invested
Capital invested by funds: $128M → $110M (-$17.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$5.2M |
| 2 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$2.72M |
| 3 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$1.69M |
| 4 |
GS
Gagnon Securities
New York
|
+$1.38M |
| 5 |
ACM
Altium Capital Management
New York
|
+$812K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$11.5M |
| 2 |
RI
RTW Investments
New York
|
-$1.79M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$433K |
| 4 |
Millennium Management
New York
|
-$426K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$419K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIC
51
Chilton Investment Company
Stamford,
Connecticut
| – | -$146K | -10,000 | Closed |
|
|
CH
52
CVI Holdings
Wilmington,
Delaware
| – | -$146K | -10,000 | Closed |
|
|
APP
53
Alpha Paradigm Partners
Chicago,
Illinois
| – | -$18K | -1,262 | Closed |
|
54
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$5.82K | -466 | -98% |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$2.71K | -217 | Closed |
|
56
JP Morgan Chase
New York
| – | -$3K | -202 | Closed |
|
|
SPIA
57
Steward Partners Investment Advisory
New York
| – | -$3K | -200 | Closed |
|
PROF Hedge Fund Activity: Q4 2021 in Review
46 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2021, worth a combined $110M — down 14% from $128M a quarter earlier.
Fund positioning in PROF was balanced in Q4 2021: 11 funds opened new positions, 11 closed out, 16 added to existing stakes and 9 trimmed.
The largest buyer was Deerfield Management, adding an estimated $5.2M. The largest seller was Redmile Group, exiting entirely with an estimated $11.5M sold.
- 46 institutional investors held Profound Medical (PROF) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $110M of Profound Medical stock for Q4 2021, down 14% quarter-over-quarter.
- 11 funds opened new Profound Medical positions in Q4 2021 and 11 closed out, a net change of 0 holders.
- The largest Profound Medical buyer in Q4 2021 was Deerfield Management, an estimated $5.2M added.
- The largest Profound Medical seller in Q4 2021 was Redmile Group, an estimated $11.5M sold.
Based on aggregated 13F filings for Q4 2021.